CRL · 8-K · 20260805PR000115
Capital Return Program
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · 2026-08-05 · Importance 50 · Surprise 24 · In source text
Charles River repurchased $100.0 million of common stock during the second quarter at an average price of $174 per share. Year-to-date repurchases totaled $300.0 million for 1.7 million shares through June 27, 2026. The company had $700.0 million remaining under its $1.0 billion authorization approved by the board on October 29, 2025. Treasury-stock purchases totaled $323.9 million in the first six months, and diluted weighted-average shares declined to 48.0 million from 49.3 million in the quarter.
Key facts
- As of June 27, 2026, $700.0 million remained under the $1.0 billion stock repurchase authorization approved October 29, 2025. source
- Year-to-date through June 27, 2026, the Company repurchased 1.7 million shares for a total of $300.0 million, including 0.6 million shares for $100.0 million in Q2 2026. source
- Repurchased $100 million of common stock in the second quarter at an average price of $174 per share. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| cash | negative | realized | -4.0% | Year-to-date through June 27, 2026, the Company repurchased 1.7 million shares for a total of $300.0 million, including 0.6 million shares… |
| cash | negative | realized | — | Repurchased $100 million of common stock in the second quarter at an average price of $174 per share. |